Network Analysis of Gut Microbiome and Metabolome to Discover Microbiota-Linked Biomarkers in Patients Affected by Non-Small Cell Lung Cancer.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
19 Nov 2020
Historique:
received: 23 10 2020
revised: 13 11 2020
accepted: 16 11 2020
entrez: 24 11 2020
pubmed: 25 11 2020
medline: 5 3 2021
Statut: epublish

Résumé

Several studies in recent times have linked gut microbiome (GM) diversity to the pathogenesis of cancer and its role in disease progression through immune response, inflammation and metabolism modulation. This study focused on the use of network analysis and weighted gene co-expression network analysis (WGCNA) to identify the biological interaction between the gut ecosystem and its metabolites that could impact the immunotherapy response in non-small cell lung cancer (NSCLC) patients undergoing second-line treatment with anti-PD1. Metabolomic data were merged with operational taxonomic units (OTUs) from 16S RNA-targeted metagenomics and classified by chemometric models. The traits considered for the analyses were: (i) condition: disease or control (CTRLs), and (ii) treatment: responder (R) or non-responder (NR). Network analysis indicated that indole and its derivatives, aldehydes and alcohols could play a signaling role in GM functionality. WGCNA generated, instead, strong correlations between short-chain fatty acids (SCFAs) and a healthy GM. Furthermore, commensal bacteria such as

Identifiants

pubmed: 33227982
pii: ijms21228730
doi: 10.3390/ijms21228730
pmc: PMC7699235
pii:
doi:

Substances chimiques

Alcohols 0
Aldehydes 0
Antineoplastic Agents, Immunological 0
Fatty Acids, Volatile 0
Indoles 0
PDCD1 protein, human 0
Programmed Cell Death 1 Receptor 0
RNA, Ribosomal, 16S 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Biomed Res Int. 2017;2017:5958321
pubmed: 28386558
Pathog Dis. 2018 Jun 1;76(4):
pubmed: 29668928
BMC Microbiol. 2016 May 25;16:90
pubmed: 27220822
Gut Microbes. 2019;10(3):398-411
pubmed: 30359553
Cell. 2016 Apr 7;165(2):276-87
pubmed: 27058662
Oncotarget. 2018 Apr 3;9(25):17915-17927
pubmed: 29707157
PLoS Pathog. 2018 Sep 12;14(9):e1007191
pubmed: 30208103
FEMS Microbiol Ecol. 2018 Sep 1;94(9):
pubmed: 29982420
Nat Rev Immunol. 2013 May;13(5):321-35
pubmed: 23618829
Cancer Immunol Res. 2020 Oct;8(10):1243-1250
pubmed: 32847937
Mediators Inflamm. 2019 Nov 11;2019:7652014
pubmed: 31827379
Sci Rep. 2017 Mar 20;7:44797
pubmed: 28317894
Cell Death Differ. 2015 Feb;22(2):199-214
pubmed: 24832470
FASEB J. 2007 Jun;21(8):1675-88
pubmed: 17314143
J Exp Clin Cancer Res. 2019 Jun 19;38(1):268
pubmed: 31217020
Nat Commun. 2018 Aug 17;9(1):3294
pubmed: 30120222
Nature. 1998 Jun 4;393(6684):440-2
pubmed: 9623998
PLoS One. 2015 Feb 17;10(2):e0116533
pubmed: 25689583
Trends Microbiol. 2017 Mar;25(3):217-228
pubmed: 27916383
Front Neuroinform. 2018 Mar 15;12:7
pubmed: 29599714
PLoS One. 2018 Dec 6;13(12):e0208171
pubmed: 30521551
J Agric Food Chem. 2019 Feb 6;67(5):1381-1391
pubmed: 30644740
Nat Rev Microbiol. 2017 Oct;15(10):630-638
pubmed: 28626231
Nutr Res Rev. 2015 Jun;28(1):42-66
pubmed: 26156216
J Oncol. 2017;2017:5035371
pubmed: 29075294
Cancer Res. 1994 Jun 15;54(12):3288-93
pubmed: 8205551
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2658-63
pubmed: 14981240
Appl Environ Microbiol. 2006 Jul;72(7):5069-72
pubmed: 16820507
Cell. 2017 Apr 20;169(3):547-558.e15
pubmed: 28431252
Nature. 2014 Jan 23;505(7484):559-63
pubmed: 24336217
J Nutr. 2013 Oct;143(10):1549-57
pubmed: 23946343
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Nat Commun. 2016 Feb 02;7:10391
pubmed: 26837003
Clin Gastroenterol Hepatol. 2013 Jul;11(7):868-75.e1-3
pubmed: 23454028
Front Microbiol. 2016 Jul 26;7:1144
pubmed: 27507964
Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):182-95
pubmed: 20056637
Bioinformatics. 2004 Sep 22;20(14):2242-50
pubmed: 15130938
Science. 2018 Jan 5;359(6371):97-103
pubmed: 29097493
Science. 2015 Nov 27;350(6264):1084-9
pubmed: 26541606
Ecancermedicalscience. 2018 Sep 05;12:866
pubmed: 30263057
CA Cancer J Clin. 2017 Jul 8;67(4):326-344
pubmed: 28481406
Nature. 2004 Jul 1;430(6995):88-93
pubmed: 15190252
J Immunother Cancer. 2019 Apr 17;7(1):108
pubmed: 30995949
Science. 2013 Nov 22;342(6161):971-6
pubmed: 24264990
Stat Appl Genet Mol Biol. 2005;4:Article17
pubmed: 16646834
Bioinformatics. 2010 Jan 15;26(2):266-7
pubmed: 19914921
Nucleic Acids Res. 2013 Jan;41(Database issue):D801-7
pubmed: 23161693
J Transl Med. 2020 Feb 3;18(1):49
pubmed: 32014010
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
Science. 2015 Nov 27;350(6264):1079-84
pubmed: 26541610
Immunity. 2013 Jul 25;39(1):1-10
pubmed: 23890059
Science. 2018 Jan 5;359(6371):91-97
pubmed: 29097494
Nat Med. 2016 Jun;22(6):586-97
pubmed: 27158906
Anal Bioanal Chem. 2017 Sep;409(24):5689-5696
pubmed: 28717894
Gut Pathog. 2020 Sep 10;12:43
pubmed: 32944086
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Science. 2018 Mar 23;359(6382):1350-1355
pubmed: 29567705
J Anal Methods Chem. 2019 Sep 10;2019:7247802
pubmed: 31583160
J Thorac Oncol. 2019 Aug;14(8):1378-1389
pubmed: 31026576
Science. 2013 Nov 22;342(6161):967-70
pubmed: 24264989
Clin J Am Soc Nephrol. 2012 Jun;7(6):982-8
pubmed: 22490877

Auteurs

Pamela Vernocchi (P)

Area of Genetics and Rare Diseases, Unit of Human Microbiome, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.

Tommaso Gili (T)

IMT School for Advanced Studies Lucca, Networks Unit, 55100 Lucca, Italy.

Federica Conte (F)

Institute for Systems Analysis and Computer Science "Antonio Ruberti", National Research Council, 00185 Rome, Italy.

Federica Del Chierico (F)

Area of Genetics and Rare Diseases, Unit of Human Microbiome, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.

Giorgia Conta (G)

Department of Chemistry, NMR-Based Metabolomics Laboratory Sapienza, University of Rome, 00185 Rome, Italy.

Alfredo Miccheli (A)

Department of Environmental Biology and NMR-Based Metabolomics Laboratory, Sapienza University of Rome, 00185 Rome, Italy.

Andrea Botticelli (A)

Department of Clinical and Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy.
AOU Policlinico Umberto I, 00161 Rome, Italy.

Paola Paci (P)

Department of Computer, Control and Management Engineering, Sapienza University of Rome, 00185 Rome, Italy.

Guido Caldarelli (G)

Department of Molecular Sciences and Nanosystems, Ca' Foscari, University of Venice, 30172 Venice, Italy.
European Centre for Living Technologies, 30172 Venice, Italy.
Institute of Complex Systems (CNR), Department of Physics, University of Rome "Sapienza", 00185 Rome, Italy.

Marianna Nuti (M)

Department of Experimental Medicine, University Sapienza of Rome, 00185 Rome, Italy.

Paolo Marchetti (P)

Department of Clinical and Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy.
AOU Policlinico Umberto I, 00161 Rome, Italy.
AOU Sant' Andrea Hospital, 00189 Rome, Italy.

Lorenza Putignani (L)

Department of Diagnostic and Laboratory Medicine, Unit of Parasitology and Area of Genetics and Rare Diseases, Unit of Human Microbiome, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH